Cargando…

Does dexmedetomidine have an antiarrhythmic effect on cardiac patients? A meta-analysis of randomized controlled trials

BACKGROUND: Cardiac surgery patients often experience several types of tachyarrhythmias after admission to the intensive care unit (ICU), which increases mortality and morbidity. Dexmedetomidine (DEX) is a popular medicine used for sedation in the ICU, and its other pharmacological characteristics a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ling, Xiaoyan, Zhou, Hongmei, Ni, Yunjian, Wu, Cheng, Zhang, Caijun, Zhu, Zhipeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832237/
https://www.ncbi.nlm.nih.gov/pubmed/29494685
http://dx.doi.org/10.1371/journal.pone.0193303
_version_ 1783303293244538880
author Ling, Xiaoyan
Zhou, Hongmei
Ni, Yunjian
Wu, Cheng
Zhang, Caijun
Zhu, Zhipeng
author_facet Ling, Xiaoyan
Zhou, Hongmei
Ni, Yunjian
Wu, Cheng
Zhang, Caijun
Zhu, Zhipeng
author_sort Ling, Xiaoyan
collection PubMed
description BACKGROUND: Cardiac surgery patients often experience several types of tachyarrhythmias after admission to the intensive care unit (ICU), which increases mortality and morbidity. Dexmedetomidine (DEX) is a popular medicine used for sedation in the ICU, and its other pharmacological characteristics are gradually being uncovered. PURPOSE: To determine whether DEX has an antiarrhythmic effect after cardiac surgery. METHODS: The three primary databases MEDLINE, Embase (OVID SP) and the Cochrane Central Register of Controlled Trials (CENTRAL) were searched, and all English-language and randomized control-designed clinical publications comparing DEX to control medicines for sedation after elective cardiac surgery were included. Two colleagues independently extracted the data and performed other quality assessments. A subgroup analysis was performed according to the different medicines used and whether cardiopulmonary bypass (CPB) was applied. All tachyarrhythmias that occurred in the atria and ventricles were analyzed. RESULTS: A total of 1295 patients in 9 studies met the selection criteria among 2587 studies that were screened. After quantitative synthesis, our results revealed that the DEX group was associated with a lower incidence of ventricular arrhythmia (VA, OR 0.24, 95% CI 0.09–0.64, I(2) = 0%, P = 0.005) than the control group. Subgroup analysis did not reveal a significant difference between the DEX and propofol subgroups (OR 0.13, 95% CI 0.03–0.56, I(2) = 0%, P = 0.007). Additionally, no difference in the incidence of atrial fibrillation (AF) was observed regardless of the different control medicines (OR 0.82, 95% CI 0.60–1.10, I(2) = 25%, P = 0.19) or whether CPB was applied. CONCLUSIONS: This meta-analysis revealed that DEX has an antiarrhythmic effect that decreases the incidence of VA compared to other drugs used for sedation following cardiac surgery. DEX may not have an effect on AF, but cautious interpretation should be exercised due to high heterogeneity.
format Online
Article
Text
id pubmed-5832237
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-58322372018-03-23 Does dexmedetomidine have an antiarrhythmic effect on cardiac patients? A meta-analysis of randomized controlled trials Ling, Xiaoyan Zhou, Hongmei Ni, Yunjian Wu, Cheng Zhang, Caijun Zhu, Zhipeng PLoS One Research Article BACKGROUND: Cardiac surgery patients often experience several types of tachyarrhythmias after admission to the intensive care unit (ICU), which increases mortality and morbidity. Dexmedetomidine (DEX) is a popular medicine used for sedation in the ICU, and its other pharmacological characteristics are gradually being uncovered. PURPOSE: To determine whether DEX has an antiarrhythmic effect after cardiac surgery. METHODS: The three primary databases MEDLINE, Embase (OVID SP) and the Cochrane Central Register of Controlled Trials (CENTRAL) were searched, and all English-language and randomized control-designed clinical publications comparing DEX to control medicines for sedation after elective cardiac surgery were included. Two colleagues independently extracted the data and performed other quality assessments. A subgroup analysis was performed according to the different medicines used and whether cardiopulmonary bypass (CPB) was applied. All tachyarrhythmias that occurred in the atria and ventricles were analyzed. RESULTS: A total of 1295 patients in 9 studies met the selection criteria among 2587 studies that were screened. After quantitative synthesis, our results revealed that the DEX group was associated with a lower incidence of ventricular arrhythmia (VA, OR 0.24, 95% CI 0.09–0.64, I(2) = 0%, P = 0.005) than the control group. Subgroup analysis did not reveal a significant difference between the DEX and propofol subgroups (OR 0.13, 95% CI 0.03–0.56, I(2) = 0%, P = 0.007). Additionally, no difference in the incidence of atrial fibrillation (AF) was observed regardless of the different control medicines (OR 0.82, 95% CI 0.60–1.10, I(2) = 25%, P = 0.19) or whether CPB was applied. CONCLUSIONS: This meta-analysis revealed that DEX has an antiarrhythmic effect that decreases the incidence of VA compared to other drugs used for sedation following cardiac surgery. DEX may not have an effect on AF, but cautious interpretation should be exercised due to high heterogeneity. Public Library of Science 2018-03-01 /pmc/articles/PMC5832237/ /pubmed/29494685 http://dx.doi.org/10.1371/journal.pone.0193303 Text en © 2018 Ling et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Ling, Xiaoyan
Zhou, Hongmei
Ni, Yunjian
Wu, Cheng
Zhang, Caijun
Zhu, Zhipeng
Does dexmedetomidine have an antiarrhythmic effect on cardiac patients? A meta-analysis of randomized controlled trials
title Does dexmedetomidine have an antiarrhythmic effect on cardiac patients? A meta-analysis of randomized controlled trials
title_full Does dexmedetomidine have an antiarrhythmic effect on cardiac patients? A meta-analysis of randomized controlled trials
title_fullStr Does dexmedetomidine have an antiarrhythmic effect on cardiac patients? A meta-analysis of randomized controlled trials
title_full_unstemmed Does dexmedetomidine have an antiarrhythmic effect on cardiac patients? A meta-analysis of randomized controlled trials
title_short Does dexmedetomidine have an antiarrhythmic effect on cardiac patients? A meta-analysis of randomized controlled trials
title_sort does dexmedetomidine have an antiarrhythmic effect on cardiac patients? a meta-analysis of randomized controlled trials
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832237/
https://www.ncbi.nlm.nih.gov/pubmed/29494685
http://dx.doi.org/10.1371/journal.pone.0193303
work_keys_str_mv AT lingxiaoyan doesdexmedetomidinehaveanantiarrhythmiceffectoncardiacpatientsametaanalysisofrandomizedcontrolledtrials
AT zhouhongmei doesdexmedetomidinehaveanantiarrhythmiceffectoncardiacpatientsametaanalysisofrandomizedcontrolledtrials
AT niyunjian doesdexmedetomidinehaveanantiarrhythmiceffectoncardiacpatientsametaanalysisofrandomizedcontrolledtrials
AT wucheng doesdexmedetomidinehaveanantiarrhythmiceffectoncardiacpatientsametaanalysisofrandomizedcontrolledtrials
AT zhangcaijun doesdexmedetomidinehaveanantiarrhythmiceffectoncardiacpatientsametaanalysisofrandomizedcontrolledtrials
AT zhuzhipeng doesdexmedetomidinehaveanantiarrhythmiceffectoncardiacpatientsametaanalysisofrandomizedcontrolledtrials